Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
events

3 min read • June 9, 2025
EXCLUSIVE: Cannabis ETF Leaders Highlight Convenience For Investors, Growth Opportunities — ‘I Don’t Think Cannabis Is Uninvestable’

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Canopy Growth CLO, Christelle Gedeon Says During Cannabis M&A Deals ‘You Need To Be An Excellent Operator To Be Successful’ Says Cannabis M&As Are Complicated Because Each States Have Their Own Laws

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Bianchi & Brandt Co-Founder, Laura Bianchi Says Cross-State M&A And License Deal Structures Are Complicated, Says Process Can Be Slow And All Parties Should Be On The Same Page

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Verano CIO, Aaron Miles Says In The Cannabis Industry ‘Cash Is King Now’

4 min read • June 9, 2025
EXCLUSIVE: Tobacco Sector Looks To Cannabis For Growth: ‘Investments Are Meant For A Very Specific Reason’

3 min read • June 9, 2025
EXCLUSIVE: Cresco Labs CEO Says Cannabis Industry To Hold White House Accountable For Campaign Promises: ‘We’ll Take Any Movement At A Federal Level’

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: C3 Industries CEO, Ankur Rugta Says It Is Very Hard To Do M&A Deals Right Now, Says Currently Institutional Equity Is Non-Existent In The Cannabis Sector

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Next Titan Capital Co-Founder, Jade Green Says Currently The Cannabis M&A Market Is Distressed

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Organigram CEO Beena Goldenberg Says Tobacco Is Looking For Non-Combustible Products

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Cresco Labs CEO, Charlie Bachtell Says There Are Still States Where The Company Can Get Into, Says Company Is Back In Acquisitive Mode

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Cresco Labs CEO, Charlie Bachtell Says ‘Rescheduling Is An Administrative Process Which By In Large Is Not Impacted By Debates Over Bigger Agenda Items That Could Get In The Way Of Progress’

1 min read • June 9, 2025
From Benzinga’s Cannabis Capital Conference: Cresco Labs CEO, Charlie Bachtell Says Cannabis Was Not On The Administration’s First 100 Day List, Says We Need To Find The Opportunity To Let Them Go Through The Initiatives
Latest Headlines
View All
2 min read • June 5, 2026
Industry Groups Slam NY Cannabis Wage Bill Over Transparency And Cost Concerns
1 min read • June 5, 2026
Trulieve Executes Major Asset Reorganization Ahead Of Potential NYSE Debut
2 min read • June 5, 2026
As THC Beverages Surge, WSWA Steps Into The Conversation In Chicago
4 min read • June 5, 2026
Charlotte’s Web CEO Sees Healthcare Integration And Industry Alignment Driving The Next Phase Of Cannabinoid Growth
4 min read • June 5, 2026
Cannabis Investors Want Cash Flow, Not Growth-At-All-Costs, Says New Holland Founder
3 min read • June 4, 2026
Capital Still Flowing Into Cannabis, But Only For Companies That Can Scale
3 min read • June 4, 2026
Jushi’s Strategy Chief On Markets, Regulation, and The Value Of Showing Up In Chicago
5 min read • June 4, 2026
Building a Cannabis Business That Survives the Down Cycles
2 min read • June 3, 2026
Europe Emerging As Overlooked Opportunity In Global Cannabis Expansion, Says SOMAÍ Founder
2 min read • June 3, 2026
Kentucky Cannabis Program Sees Regulatory Clarification, Expanding List Of Treatable Conditions
5 min read • June 3, 2026
The Biggest Compliance Risk In Cannabis Might Already Be Inside Your Company
2 min read • June 3, 2026
This Cannabis Co. Hands Over Core US Assets To Lender-Backed Entity After Restructuring Agreement
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis earnings
cannabis farms
cannabis study
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
Hot
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.
